Neurobiology of delusions, memory, and insight in alzheimer disease

American Journal of Geriatric Psychiatry

Volumn 22, Issue 11, 2014, Pages 1346-1355

  Sultzer, David L ^a,b   Leskin, Lorraine P ^a   Melrose, Rebecca J ^a,b   Harwood, Dylan G ^a,b   Narvaez, Theresa A ^a   Ando, Timothy K ^a   Mandelkern, Mark A ^a,c  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer disease; cerebral metabolism; delusions; FDG PET; insight; memory

Indexed keywords

FLUORODEOXYGLUCOSE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; CROSS-SECTIONAL STUDY; DELUSION; DELUSIONAL DISORDER; DEMENTIA RATING SCALE; DISEASE ASSOCIATION; FEMALE; FRONTAL CORTEX; HUMAN; MAJOR CLINICAL STUDY; MALE; MATTIS DEMENTIA RATING SCALE; MEMORY DISORDER; MENTAL DISEASE ASSESSMENT; MINI MENTAL STATE EXAMINATION; NEUROBEHAVIORAL RATING SCALE; NEUROBIOLOGY; NEUROPSYCHIATRIC INVENTORY; ORBITAL CORTEX; OUTPATIENT; POSITRON EMISSION TOMOGRAPHY; TEMPORAL CORTEX; BRAIN; COMPLICATION; COMPREHENSION; DELUSIONS; MEMORY DISORDERS; METABOLISM; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY;

AGED; ALZHEIMER DISEASE; BRAIN; COMPREHENSION; CROSS-SECTIONAL STUDIES; DELUSIONS; FEMALE; HUMANS; MALE; MEMORY DISORDERS; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY;

EID: 84920181195     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2013.06.005     Document Type: Article

References (59)

1. Ropacki SA, Jeste DV: Epidemiology of and risk factors for psychosis of Alzheimer's disease: A review of 55 studies published from 1990-2003. Am J Psychiatry 2005; 162:2022-2030
2. Donaldson C, Tarrier N, Burns A: The impact of the symptoms of dementia on caregivers. Br J Psychiatry 1997; 170:62-68
3. Magni E, Binetti G, Bianchetti A, et al: Risk of mortality and institutionalization in demented patients with delusions. J Geriatr Psychiatry Neurol 1996; 9:123-126
4. Mizrahi R, Starkstein SE, Jorge R, et al: Phenomenology and clinical correlates of delusions in Alzheimer's disease. Am J Geriatr Psychiatry 2006; 14:573-581
5. Spalletta G, Musicco M, Padovani A, et al: Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease. Am J Geriatr Psychiatry 2010; 18:1026-1035
6. Koppel J, Goldberg TE, Gordon ML, et al: Relationships between behavioral syndromes and cognitive domains in Alzheimer disease: The impact of mood and psychosis. Am J Geriatr Psychiatry 2012; 20:994-1000
7. Starkstein SE, Sabe L, Chemerinski E, et al: Two domains of anosognosia in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996; 61:485-490
8. Aalten P, Van Valen E, Clare L, et al: Awareness in dementia: A review of clinical correlates. Aging Ment Health 2005; 9: 414-422
9. Kazui H, Hirono N, Hashimoto M, et al: Symptoms underlying unawareness of memory impairment in patients with mild Alzheimer's disease. J Geriatr Psychiatry Neurol 2006; 19:3-12
10. Sultzer DL, Brown CV, Mandelkern MA, et al: Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease. Am J Psychiatry 2003; 160:341-349
11. Staff RT, Shanks MF, Macintosh L, et al: Delusions in Alzheimer's disease: SPET evidence of right hemispheric dysfunction. Cortex 1999; 35:549-560
12. Nakano S, Yamashita F, Matsuda H, et al: Relationship between delusions and regional cerebral blood flow in Alzheimer's disease. Dement Geriatr Cogn Disord 2006; 21:16-21
13. Starkstein SE, Vazquez S, Petracca G, et al: A SPECT study of delusions in Alzheimer's disease. Neurology 1994; 44:2055-2059
14. Mentis MJ, Weinstein EA, Horwitz B, et al: Abnormal brain glucose metabolism in the delusional misidentification syndromes: A positron emission tomography study in Alzheimer disease. Biol Psychiatry 1995; 38:438-449
15. Ismail Z, Nguyen M-Q, Fischer CE, et al: Neuroimaging of delusions in Alzheimer's disease. Psychiatry Res Neuroimag 2012; 202:89-95
16. Harwood DG, Sultzer DL, Feil D, et al: Frontal lobe hypometabolism and impaired insight in Alzheimer disease. Am J Geriatr Psychiatry 2005; 13:934-941
17. Reed BR, Jagust WJ, Coulter L: Anosognosia in Alzheimer's disease: Relationships to depression, cognitive function, and cerebral perfusion. J Clin Exp Neuropsychol 1993; 15:231-244
18. McKhann GM, Knopman DS, Chertkow H, et al: The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheim Dement 2011; 7:263-269
19. Cummings JL, Mega M, Gray K, et al: The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308-2314
20. Sultzer DL, Levin HS, Mahler ME, et al: Assessment of cognitive, psychiatric, and behavioral disturbances in patients with dementia: The Neurobehavioral Rating Scale. J Am Geriatr Soc 1992; 40:549-555
21. Sultzer DL, Berisford MA, Gunay I: The Neurobehavioral Rating Scale: Reliability in patients with dementia. J Psychiatr Res 1995; 29:185-191
22. Mattis S: Mental status examination for organic mental syndrome in the elderly patient, in Geriatric Psychiatry. Edited by Bellak L, Karasu TB. New York, Grune and Stratton, 1976, pp 77-107
23. Gardner R Jr, Oliver-Munoz S, Fisher L, et al: Mattis Dementia Rating Scale: Internal reliability study using a diffusely impaired population. J Clin Neuropsychol 1981; 3:271-275
24. Vitaliano PP, Breen AR, Russo J, et al: The clinical utility of the dementia rating scale for assessing Alzheimer patients. J Chronic Dis 1984; 37:743-753
25. Hamacher K, Coenen HH, Stocklin G: Efficient stereospecific synthesis of no-carrier-added 2-18F-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27:235-238
26. Sweet RA, Bennett DA, Graff-Radford NR, et al: Assessment and familial aggregation of psychosis in Alzheimer's disease from the NIA Late Onset Alzheimer's Disease Family Study. Brain 2010; 133:1155-1162
27. Lai MKP, Lai O-F, Keene J, et al: Psychosis of Alzheimer's disease is associated with elevated muscarinic M2 binding in the cortex. Neurology 2001; 57:805-811
28. Farber NB, Rubin EH, Newcomer JW, et al: Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis. Arch Gen Psychiatry 2000; 57: 1165-1173
29. Murray PS, Kirkwood CM, Gray MC, et al: Beta-amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis. Neurobiol Aging 2012; 33:2807-2816
30. Kotrla KJ, Chacko RC, Harper RG, et al: SPECT findings on psychosis in Alzheimer's disease. Am J Psychiatry 1995; 152: 1470-1475
31. Sultzer DL, Mahler ME, Mandelkern MA, et al: The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1995; 7: 476-484
32. Staff RT, Venneri A, Gemmell HG, et al: HMPAO SPECT imaging of Alzheimer's disease patients with similar content-specific autobiographic delusion: Comparison using statistical parametric mapping. J Nucl Med 2000; 41:1451-1455
33. Moran EK, Becker JA, Satlin A, et al: Psychosis of Alzheimer's disease: Gender differences in regional perfusion. Neurobiol Aging 2008; 29:1218-1225
34. Hirono N, Mori E, Yasuda M, et al: Factors associated with psychotic symptoms in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1998; 64:648-652
35. Mega MS, Lee L, Dinov ID, et al: Cerebral correlates of psychotic symptoms in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2000; 69:167-171
36. Fukuhara R, Ikeda M, Nebu A, et al: Alteration of rCBF in Alzheimer's disease patients with delusions of theft. Neuroreport 2001; 12:2473-2476
37. Barbey AK, Koenigs M, Grafman J: Orbitofrontal contributions to human working memory. Cereb Cortex 2011; 21:789-795
38. Wager TD, Smith EE: Neuroimaging studies of working memory: A meta-analysis. Cogn Affect Behav Neurosci 2003; 3:255-274
39. Golby A, Silverberg G, Race E, et al: Memory encoding in Alzheimer's disease: An fMRI study of explicit and implicit memory. Brain 2005; 128:773-787
40. Pariente J, Cole S, Henson R, et al: Alzheimer's patients engage an alternative network during a memory task. Ann Neurol 2005; 58: 870-879
41. Remy F, Mirrashed F, Campbell B, et al: Verbal episodic memory impairment in Alzheimer's disease: A combined structural and functional MRI study. Neuroimage 2005; 25:253-266
42. Braak E, Griffing K, Arai K, et al: Neuropathology of Alzheimer's disease: What is new since A. Alzheimer? Eur Arch Psychiatry Clin Neurosci 1999; 249(suppl 3):14-22
43. Schwindt GC, Black SE: Functional imaging studies of episodic memory in Alzheimer's disease: A quantitative meta-analysis. Neuroimage 2009; 45:181-190
44. Squire LR, Stark CE, Clark RE: The medial temporal lobe. Annu Rev Neurosci 2004; 27:279-306
45. Lopez OL, Becker JT, Somsak D, et al: Awareness of cognitive deficits and anosognosia in probable Alzheimer's disease. Eur Neurol 1994; 34:277-282
46. Harwood DG, Sultzer DL, Wheatley MV: Impaired insight in Alzheimer disease: Association with cognitive deficits, psychiatric symptoms, and behavioral disturbances. Neuropsychiatry Neuropsychol Behav Neurol 2000; 13:83-88
47. Mangone CA, Hier DB, Gorelick PB, et al: Impaired insight in Alzheimer's disease. J Geriatr Psychiatry Neurol 1991; 4:189-193
48. Hanyu H, Sato T, Akai T, et al: Neuroanatomical correlates of unawareness of memory deficits in early Alzheimer's disease. Dement Geriatr Cogn Disord 2008; 25:347-353
49. Ott BR, Noto RB, Fogel BS: Apathy and loss of insight in Alzheimer's disease: A SPECT imaging study. J Neuropsychiatry Clin Neurosci 1996; 8:41-46
50. Starkstein SE, Vazquez S, Migliorelli R, et al: A single-photon emission computed tomographic study of anosognosia in Alzheimer's disease. Arch Neurol 1995; 52:415-420
51. Shibata K, Narumoto J, Kitabayashi Y, et al: Correlation between anosognosia and regional cerebral blood flow in Alzheimer's disease. Neurosci Lett 2008; 435:7-10
52. Sedaghat F, Dedousi E, Baloyannis I, et al: Brain SPECT findings of anosognosia inAlzheimer's disease. J AlzheimDis 2010; 21:641-647
53. Clare L, Markova I, Verhey F, et al: Awareness in dementia: A review of assessment methods and measures. Aging Ment Health 2005; 9:394-413
54. Melrose RJ, Ettenhofer ML, Harwood D, et al: Cerebral metabolism, cognition, and functional abilities in Alzheimer disease. J Geriatr Psychiatry Neurol 2011; 24:127-134
55. Grady CL: Quantitative comparison of measurements of cerebral glucose metabolic rate made with two positron cameras. J Cereb Blood Flow Metab 1991; 11:A57eA63
56. Blackwood NJ, Howard RJ, Bentall RP, et al: Cognitive neuropsychiatric models of persecutory delusions. Am J Psychiatry 2001; 158:527-539
57. Elliott B, Joyce E, Shorvon S: Delusions, illusions and hallucinations in epilepsy. 2. Complex phenomena and psychosis. Epilepsy Res 2009; 85:172-186
58. Sultzer DL, Melrose RJ, Harwood DG, et al: Effect of memantine treatment on regional cortical metabolism in Alzheimer's disease. Am J Geriatr Psychiatry 2010; 18:606-614
59. Sultzer DL, Melrose RJ, Harwood DG, et al: Donepezil treatment and regional cortical metabolism in Alzheimer's disease: FDG-PET findings. Am J Geriatr Psychiatry 2011; 19:S124eS125